Bausch & Lomb Corp (BLCO) stock
BLCONYSEOphthalmic GoodsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3029% below fair value
$20.83−0.05 (-0.24%)
Close on Nov 17, 2026Market cap $7.45BP/E –Yield –
Bausch & Lomb operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Bausch & Lomb's operating cash flow for the twelve months ending Sep 30, 2026 was $554.00M, up 227.8% year over year. For fiscal 2025 it was $283.00M, up 22.0% from the year before. The highest annual figure on record is $873.00M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $283.00M | +22.0% |
| FY2024 | Dec 31, 2024 | $232.00M | – |
| FY2023 | Dec 31, 2023 | -$17.00M | -104.9% |
| FY2022 | Dec 31, 2022 | $345.00M | -60.5% |
| FY2021 | Dec 31, 2021 | $873.00M | +67.2% |
| FY2020 | Dec 31, 2020 | $522.00M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $233.00M | +70.1% |
| Q2 FY2026 | Jun 30, 2026 | $153.00M | +337.1% |
| Q1 FY2026 | Mar 31, 2026 | $32.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $136.00M | +518.2% |
| Q3 FY2025 | Sep 30, 2025 | $137.00M | -11.0% |
| Q2 FY2025 | Jun 30, 2025 | $35.00M | +133.3% |
| Q1 FY2025 | Mar 31, 2025 | -$25.00M | -161.0% |
| Q4 FY2024 | Dec 31, 2024 | $22.00M | +46.7% |
| Q3 FY2024 | Sep 30, 2024 | $154.00M | +220.8% |
| Q2 FY2024 | Jun 30, 2024 | $15.00M | – |
| Q1 FY2024 | Mar 31, 2024 | $41.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $15.00M | -90.6% |
| Q3 FY2023 | Sep 30, 2023 | $48.00M | +77.8% |
| Q2 FY2023 | Jun 30, 2023 | -$24.00M | -115.4% |
| Q1 FY2023 | Mar 31, 2023 | -$56.00M | -1966.7% |
| Q4 FY2022 | Dec 31, 2022 | $159.00M | -1.9% |
| Q3 FY2022 | Sep 30, 2022 | $27.00M | -90.1% |
| Q2 FY2022 | Jun 30, 2022 | $156.00M | -37.6% |
| Q1 FY2022 | Mar 31, 2022 | $3.00M | -98.4% |
| Q4 FY2021 | Dec 31, 2021 | $162.00M | – |
| Q3 FY2021 | Sep 30, 2021 | $273.00M | – |
| Q2 FY2021 | Jun 30, 2021 | $250.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $188.00M | – |
See a number that looks wrong?